Abstract:: We aimed to explore left atrial (LA) remodeling in the patients with solid cancer before initiation of chemo- or radiotherapy. This retrospective investigation included 92 chemo- and radiotherapy-naive cancer patients and 40 age- and gender-matched controls with a similar cardiovascular risk profile as the cancer group. All participants underwent comprehensive echocardiographic examination before the start of chemo- or radiotherapy. LA phasic function was evaluated in volumetric and strain method. Indexed mi… Show more
“…Recent published data has proved similar associations between LV systolic dysfunction and LA enlargement and impairment [10,28,40]. Moreover, in our diseased group, LVEF's deterioration was closely related with LA dysfunction, similar to other reports [41].…”
Purpose: The study sought to evaluate the role of CMR in characterizing LA geometry and function in patients with severe aortic stenosis (AS). Left atrial (LA) enlargement and dysfunction are closely related to AS progression, however, a CMR-based approach has not been yet appraised.Method: We prospectively evaluated 70 patients with severe AS and 70 age and gender-matched healthy volunteers. LA morphology, function and geometry were determined using CMR. A composite outcome (cardiac death, ventricular tachyarrhythmias, and heart failure hospitalization) was evaluated over a median of 31 months. Time-to-event outcomes were analyzed using Kaplan-Meier method.Results: LA volumes (LAV) were significantly increased, and LA sphericity index (LASI) was decreased (all p<.001), while LA phasic functions and strains were also considerably defective in patients with AS (all p<.001). Moreover, LA volumes were closely associated with LA atrial booster function and LA strains (all p<.0001), while LASI mostly related to LA total and active strain (p<.0001). Furthermore, LV mass (LVM), end-diastolic (LVEDV) and end-systolic volumes (LVESV) were significantly associated with all LA strains (p<.0001). In prognosis prediction, LA total (LA-et), passive (LA-ep) and active (LA-ea) strain, along with LASI were independently associated with increased risk of outcome (p<.001). Time-to-event analysis showed significantly higher risk to reach the composite outcome for LA-et>31.1 ml/m2 [HR=5.94; p=.0002)], LA-ep >14.5% [HR=4.04; p<.0009)], LA-ea<21.2% [HR=2.25; p<.04], LASI>0.5 [HR=2.24; p<.04)].Conclusion: Patients with severe AS and impaired LA geometry and function at CMR have increased risk of outcomes. LAVmin, LASI, LAPF and LA-ep were independent predictors for outcome.
“…Recent published data has proved similar associations between LV systolic dysfunction and LA enlargement and impairment [10,28,40]. Moreover, in our diseased group, LVEF's deterioration was closely related with LA dysfunction, similar to other reports [41].…”
Purpose: The study sought to evaluate the role of CMR in characterizing LA geometry and function in patients with severe aortic stenosis (AS). Left atrial (LA) enlargement and dysfunction are closely related to AS progression, however, a CMR-based approach has not been yet appraised.Method: We prospectively evaluated 70 patients with severe AS and 70 age and gender-matched healthy volunteers. LA morphology, function and geometry were determined using CMR. A composite outcome (cardiac death, ventricular tachyarrhythmias, and heart failure hospitalization) was evaluated over a median of 31 months. Time-to-event outcomes were analyzed using Kaplan-Meier method.Results: LA volumes (LAV) were significantly increased, and LA sphericity index (LASI) was decreased (all p<.001), while LA phasic functions and strains were also considerably defective in patients with AS (all p<.001). Moreover, LA volumes were closely associated with LA atrial booster function and LA strains (all p<.0001), while LASI mostly related to LA total and active strain (p<.0001). Furthermore, LV mass (LVM), end-diastolic (LVEDV) and end-systolic volumes (LVESV) were significantly associated with all LA strains (p<.0001). In prognosis prediction, LA total (LA-et), passive (LA-ep) and active (LA-ea) strain, along with LASI were independently associated with increased risk of outcome (p<.001). Time-to-event analysis showed significantly higher risk to reach the composite outcome for LA-et>31.1 ml/m2 [HR=5.94; p=.0002)], LA-ep >14.5% [HR=4.04; p<.0009)], LA-ea<21.2% [HR=2.25; p<.04], LASI>0.5 [HR=2.24; p<.04)].Conclusion: Patients with severe AS and impaired LA geometry and function at CMR have increased risk of outcomes. LAVmin, LASI, LAPF and LA-ep were independent predictors for outcome.
“…In our study, mean value of RVEDV increaseis not statistically signicant (p=0.057), however the number of patients who shows increased in RVEDV was 12.72% (7 of 55) of the patients. Inpost RT phase the mean value increased to 137.26 SD ± 4.28 which was signicant (p=0.008) similar to other studies 16. Marijana Tadic et al reported greater diameter and higher volume among patients undergoing chemotherapy and radiation.…”
This prospective single institution study was carried out with 55 patients to evaluate the cardiac functions in left sided post mastectomy breast cancer patients who received Doxorubicin based chemotherapy with chest wall irradiation. Our study reported only 18% cardiotoxicity in contrast to about 30% in similar studies. There was a decline in the left ventricular ejection fraction after chemotherapy. Radiation did not affect left ventricular function much. The right ventricular systolic dysfunction observed in our study, as depicted by the value of TAPSE decreased after chemotherapy and then after radiation. Neither age nor the use of Taxanes following Doxorubicin administration factored much. The mean cumulative dose of Doxorubicin was confined to 360 mg/m2. Radiation induced cardiac dysfunction was mainly confined to the changes in the dimensions of the ventricles and left atrium volume. Decreased cardiotoxicity observed was probably due to short follow up of 6 months.
“…LA conduit function was found to be defective even before LV hypertrophy and enlargement occurred [ 34 ], and to be directly associated with diastolic dysfunction, its severity [ 32 ] and progression [ 35 ]. Moreover, LA reservoir function was notably linked to cardiac dysfunction in diabetic [ 36 ] and cancer patients [ 37 ]. Additionally, the role of LA strain had been certified, being considerably linked to disease severity, HF hospitalization and mortality [ 38 ].…”
Left atrial (LA) geometry and phasic functions are frequently impaired in non-ischaemic dilated cardiomyopathy (NIDCM). Cardiac magnetic resonance (CMR) can accurately measure LA function and geometry parameters. We sought to investigate their prognostic role in patients with NIDCM. We prospectively examined 212 patients with NIDCM (49 ± 14.2-year-old; 73.5% males) and 106 healthy controls. LA volumes, phasic functions, geometry, and fibrosis were determined using CMR. A composite outcome (cardiac death, ventricular tachyarrhythmias, heart failure hospitalization) was ascertained over a median of 26 months. LA phasic functions, sphericity index (LASI) and late gadolinium enhancement (LA-LGE) were considerably impaired in the diseased group (p < 0.001) and significantly correlated with impaired LV function parameters (p < 0.0001). After multivariate analysis, LA volumes, LASI, LA total strain (LA-εt) and LA-LGE were associated with increased risk of composite outcome (p < 0.001). Kaplan–Meier analysis showed significantly higher risk of composite endpoint for LA volumes (all p < 0.01), LASI > 0.725 (p < 0.003), and LA-εt < 30% (p < 0.0001). Stepwise Cox proportional-hazards models demonstrated a considerable incremental predictive value which resulted by adding LASI to LA-εt (Chi-square = 10.2, p < 0.001), and afterwards LA-LGE (Chi-Square = 15.8; p < 0.0001). NIDCM patients with defective LA volumes, LASI, LA-LGE and LA-εt had a higher risk for an outcome. LA-εt, LASI and LA-LGE provided independent incremental predictive value for outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.